体外診断（IVD）品質管理の世界市場：全血ベース管理、血清ベース管理、血漿ベース管理、尿ベース管理...市場調査レポートについてご紹介

1 Introduction (Page No. – 19)
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders

2 Research Methodology (Page No. – 23)
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.2 Market Size Estimation
2.3 Market Breakdown and Data Triangulation
2.4 Market Share Estimation
2.5 Assumptions for the Study

3 Executive Summary (Page No. – 30)

4 Premium Insights (Page No. – 35)
4.1 Growth Potential of the Market
4.2 Asia-Pacific: Market
4.3 IVD Quality Control Products Market: Geographic Snapshot
4.4 Geographic Mix: IVD Quality Control Products Market
4.5 IVD Quality Control Products Market: Emerging vs. Developed Markets

5 Market Overview (Page No. – 40)
5.1 Introduction
5.2 Market Segmentation
5.2.1 IVD Quality Control Products Market, By Type
5.2.2 Market, By Application
5.2.3 Market, By Manufacturer Type
5.2.4 Market, By End User
5.3 Market Dynamics
5.3.1 Market Drivers
5.3.1.1 Growing Number of Accredited Clinical Laboratories
5.3.1.2 Increasing Adoption of Third-Party Quality Controls
5.3.2 Market Restraints
5.3.2.1 Additional Cost Involved in Quality Control, Budget Constraints in Hospitals and Laboratories
5.3.2.2 Unfavorable Reimbursement Scenario in the IVD Industry
5.3.3 Market Opportunity
5.3.3.1 Rising Demand for Multi-Analyte Controls
5.3.4 Market Challenges
5.3.4.1 Stringent Product Approval Process
5.3.4.2 Lack of Proper Regulations and Non-Compliance to Regulations

6 Industry Insights (Page No. – 49)
6.1 Introduction
6.2 Industry Trends
6.2.1 Growing Adoption of Third-Party Quality Controls
6.2.2 Increasing Focus of Customers Towards the Use of External Quality Assurance Support From Manufacturers
6.3 Porter’s Five Force Analysis
6.3.1 Threat of New Entrants
6.3.2 Threat of Substitutes
6.3.3 Bargaining Power of Suppliers
6.3.4 Bargaining Power of Buyers
6.3.5 Intensity of Competitive Rivalry
6.4 Regulatory Analysis
6.4.1 North America
6.4.1.1 U.S.
6.4.1.2 Canada
6.4.2 Europe
6.4.3 Asia-Pacific
6.4.3.1 Japan
6.4.3.2 China
6.4.3.3 India

7 Global IVD Quality Controls Products Market, By Type (Page No. – 57)
7.1 Introduction
7.2 Quality Controls
7.2.1 Whole-Blood-Based Controls
7.2.2 Serum-Based Controls
7.2.3 Plasma-Based Controls
7.2.4 Urine-Based Controls
7.2.5 Other IVD Quality Controls
7.3 Data Management Solutions
7.4 Quality Assurance Services

8 Global IVD Quality Controls Market, By Application (Page No. – 69)
8.1 Introduction
8.2 Clinical Chemistry
8.3 Immunochemistry
8.4 Hematology
8.5 Molecular Diagnostics
8.6 Coagulation/Hemostasis
8.7 Microbiology
8.8 Others

9 Global IVD Quality Controls Market, By End User (Page No. – 80)
9.1 Introduction
9.2 Hospitals
9.3 Clinical Laboratories
9.4 Research and Academic Institutes
9.5 Others

10 IVD Quality Controls Market, By Manufacturer Type (Page No. – 87)
10.1 Introduction
10.2 Instrument Manufacturer Controls
10.3 Independent Manufacturer Controls
10.3.1 Third-Party Controls
10.3.2 Instrument-Specific Controls

11 Geographic Analysis (Page No. – 94)
11.1 Introduction
11.2 North America
11.2.1 U.S.
11.2.2 Canada
11.3 Europe
11.3.1 Germany
11.3.2 France
11.3.3 U.K.
11.3.4 Italy
11.3.5 Spain
11.3.6 Rest of Europe (RoE)
11.4 Asia-Pacific (APAC)
11.4.1 Japan
11.4.2 China
11.4.3 India
11.4.4 Rest of Asia-Pacific (RoAPAC)
11.5 Latin America
11.5.1 Brazil
11.5.2 Mexico
11.5.3 Rest of Latin America (RoLA)
11.6 Middle East and Africa

12 Company Profiles (Page No. – 156)
12.1 Abbott Diagnostics
12.2 Bio-Rad Laboratories, Inc.
12.3 Roche Diagnostics
12.4 Thermo Fisher Scientific, Inc.
12.5 Randox Laboratories Ltd.
12.6 Helena Laboratories
12.7 Sero as
12.8 Seracare Life Sciences, Inc.
12.9 Technopath Clinical Diagnostics
12.10 Sun Diagnostics, LLC.
12.11 Siemens Healthcare
12.12 Sysmex Corporation
12.13 Danaher Corporation
12.14 Ortho Clinical Diagnostics, Inc.

*Details on Financials, Products & Services, Key Strategy, & Recent Developments Might Not Be Captured in Case of Unlisted Companies.

13 Competitive Landscape (Page No. – 192)
13.1 Overview
13.2 Market Share Analysis
13.3 Competitive Situation and Trends
13.4 New Product Launches
13.5 Agreements, Partnerships, and Collaborations
13.6 Mergers and Acquisitions
13.7 Expansions

14 Appendix (Page No. – 200)
14.1 Insights of Industry Experts
14.2 Discussion Guide
14.3 Other Developments, January 2012–January 2016
14.4 Introducing RT: Real-Time Market Intelligence
14.5 Available Customizations
14.6 Related Reports